Charles A. Bancroft's most recent trade in GSK Plc - ADR was a trade of 698 Ords 0.31p done at an average price of $26.4 . Disclosure was reported to the exchange on July 10, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| GSK PLC (ADR) | Charles A. Bancroft | Non-Executive Director,Senior Independent Director | Purchase of securities on an exchange or from another person at price $ 26.37 per share. | 10 Jul 2026 | 698 | 86,866 (0%) | 0% | 26.4 | 18,405 | Ords 0.31p |
| Kodiak Sciences Inc | Charles A. Bancroft | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2026 | 17,731 | 17,731 | - | - | Stock Option (Right to Buy) | |
| GSK PLC (ADR) | Charles A. Bancroft | Non-Executive Director,Senior Independent Director | Purchase of securities on an exchange or from another person at price $ 25.35 per share. | 22 Jun 2026 | 3,710 | 86,168 (0%) | 0% | 25.3 | 94,031 | Ords 0.31p |
| GSK PLC (ADR) | Charles A. Bancroft | Non-Executive Director,Senior Independent Director | Purchase of securities on an exchange or from another person at price $ 29.46 per share. | 09 Apr 2026 | 626 | 82,458 (0%) | 0% | 29.5 | 18,445 | Ords 0.31p |
| GSK PLC (ADR) | Charles A. Bancroft | Non-Executive Director,Senior Independent Director | Purchase of securities on an exchange or from another person at price $ 25.90 per share. | 20 Mar 2026 | 3,072 | 81,832 (0%) | 0% | 25.9 | 79,555 | Ords 0.31p |
| GSK PLC (ADR) | Charles A. Bancroft | Non-Executive Director,Senior Independent Director | Purchase of securities on an exchange or from another person at price $ 24.28 per share. | 19 Dec 2025 | 3,154 | 94,001 (0%) | 0% | 24.3 | 76,571 | Ords 0.31p |
| GSK PLC (ADR) | Charles A. Bancroft | Non-Executive Director,Senior Independent Director | Purchase of securities on an exchange or from another person at price $ 21.87 per share. | 10 Oct 2025 | 680 | 90,847 (0%) | 0% | 21.9 | 14,871 | Ords 0.31p |
| GSK PLC (ADR) | Charles A. Bancroft | Non-Executive Director,Senior Independent Director | Purchase of securities on an exchange or from another person at price $ 20.37 per share. | 19 Sep 2025 | 940 | 90,167 (0%) | 0% | 20.4 | 19,147 | Ords 0.31p |
| GSK PLC (ADR) | Charles A. Bancroft | Non-Executive Director,Senior Independent Director | Sale or transfer of securities back to the company at price $ 19.27 per share. | 11 Jul 2025 | 728 | 89,227 (0%) | 0% | 19.3 | 14,028 | Ords 0.31p |
| Kodiak Sciences Inc | Charles A. Bancroft | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| GSK PLC (ADR) | Charles A. Bancroft | Non-Executive Director,Senior Independent Director | Purchase of securities on an exchange or from another person at price $ 18.95 per share. | 20 Jun 2025 | 4,042 | 88,499 (0%) | 0% | 18.9 | 76,587 | Ords 0.31p |
| GSK PLC (ADR) | Charles A. Bancroft | Non-Executive Director,Senior Independent Director | Purchase of securities on an exchange or from another person at price $ 17.06 per share. | 11 Apr 2025 | 348 | 84,457 (0%) | 0% | 17.1 | 5,937 | Ords 0.31p |
| GSK PLC (ADR) | Charles A. Bancroft | Non-Executive Director,Senior Independent Director | Purchase of securities on an exchange or from another person at price $ 38.81 per share. | 25 Mar 2025 | 15,843 | 84,109 (0%) | 0% | 38.8 | 614,788 | Ords 0.31p |
| GSK PLC (ADR) | Charles A. Bancroft | Non-Executive Director,Senior Independent Director | Purchase of securities on an exchange or from another person at price $ 19.64 per share. | 20 Mar 2025 | 3,938 | 68,266 (0%) | 0% | 19.6 | 77,331 | Ords 0.31p |
| GSK PLC (ADR) | Charles A. Bancroft | Non-Executive Director,Senior Independent Director | Sale or transfer of securities back to the company at price $ 16.68 per share. | 10 Jan 2025 | 278 | 62,818 (0%) | 0% | 16.7 | 4,636 | Ords 0.31p |
| GSK PLC (ADR) | Charles A. Bancroft | Non-Executive Director,Senior Independent Director | Purchase of securities on an exchange or from another person at price $ 16.90 per share. | 20 Dec 2024 | 4,368 | 62,540 (0%) | 0% | 16.9 | 73,840 | Ords 0.31p |
| GSK PLC (ADR) | Charles A. Bancroft | Non-Executive Director,Senior Independent Director | Sale or transfer of securities back to the company at price $ 19.53 per share. | 11 Oct 2024 | 210 | 58,172 (0%) | 0% | 19.5 | 4,101 | Ords 0.31p |
| GSK PLC (ADR) | Charles A. Bancroft | Non-Executive Director,Senior Independent Director | Purchase of securities on an exchange or from another person at price $ 20.51 per share. | 23 Sep 2024 | 3,602 | 57,962 (0%) | 0% | 20.5 | 73,862 | Ords 0.31p |
| GSK PLC (ADR) | Charles A. Bancroft | Non-Executive Director,Senior Independent Director | Sale or transfer of securities back to the company at price $ 19.67 per share. | 12 Jul 2024 | 168 | 54,360 (0%) | 0% | 19.7 | 3,304 | Ords 0.31p |
| Kodiak Sciences Inc | Charles A. Bancroft | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2024 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| GSK PLC (ADR) | Charles A. Bancroft | Non-Executive Director,Senior Independent Director | Purchase of securities on an exchange or from another person at price $ 20.38 per share. | 20 Jun 2024 | 3,622 | 54,192 (0%) | 0% | 20.4 | 73,825 | Ords 0.31p |
| GSK PLC (ADR) | Charles A. Bancroft | Non-Executive Director,Senior Independent Director | Purchase of securities on an exchange or from another person at price $ 20.48 per share. | 12 Apr 2024 | 136 | 50,570 (0%) | 0% | 20.5 | 2,785 | Ords 0.31p |
| GSK PLC (ADR) | Charles A. Bancroft | Non-Executive Director,Senior Independent Director | Purchase of securities on an exchange or from another person at price $ 20.95 per share. | 20 Mar 2024 | 3,306 | 50,434 (0%) | 0% | 21.0 | 69,265 | Ords 0.31p |
| GSK PLC (ADR) | Charles A. Bancroft | Non-Executive Director,Senior Independent Director | Purchase of securities on an exchange or from another person at price $ 20.05 per share. | 12 Jan 2024 | 92 | 45,710 (0%) | 0% | 20.1 | 1,845 | Ords 0.31p |
| Kodiak Sciences Inc | Charles A. Bancroft | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Kodiak Sciences Inc | Charles A. Bancroft | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) |